Avital Mendelson

Avital Mendelson

Auto-generated profile, based on publicly available information

Avital Mendelson

New York Blood Center

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2014 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AMAvital Mendelson
Avital Mendelson
PFPaul S Frenette
Paul S Frenette

1 August 2010 in The Lancet
Verified
Journal Article
Closed access
CLChang H Lee
Chang H Lee
JCJames L Cook
James L Cook
AMAvital Mendelson
Avital Mendelson
EMEduardo K Moioli
Eduardo K Moioli
HYHai Yao
Hai Yao
JMJeremy J Mao
Jeremy J Mao

1 May 2014 in Developmental Cell
Verified
Journal Article
Closed access
TMToshihide Mizoguchi
Toshihide Mizoguchi
SPSandra Pinho
Sandra Pinho
JAJalal Ahmed
Jalal Ahmed
YKYuya Kunisaki
Yuya Kunisaki
MHMaher Hanoun
Maher Hanoun
PFPaul S. Frenette
Paul S. Frenette

8 January 2016 in Science
Verified
Journal Article
Closed access
PDF file
JKJalal A. Khan
Jalal A. Khan
AMAvital Mendelson
Avital Mendelson
YKYuya Kunisaki
Yuya Kunisaki
Alexander BirbrairAlexander Birbrair
Alexander Birbrair
YKYan Kou
Yan Kou
PFPaul S. Frenette
Paul S. Frenette
How HSCs populate the fetal liver: Hematopoietic stem cells (HSCs) undergo dramatic expansion in the fetal liver before migrating to their definitive site in the bone marrow. Khan et al. identify portal vessel–associated Nestin + NG2 + pericytes as critical HSC niche components (see the Perspective by Cabezas-Wallscheid and Trumpp). The portal vessel niche and HSCs expand according to fractal geometries, suggesting that niche cells—rather than factors expressed by the niche—drive HSC proliferation. After birth, arterial portal vessels transform into portal veins, and lose Nestin + NG2 + pericytes. When this happens, the niche is lost and HSCs migrate away from the neonatal liver. Science , this issue p. 176 ; see also p. 126

1 August 2019 in Blood
Verified
Journal Article
Open access
PDF file
WLWei Li
Wei Li
YWYaomei Wang
Yaomei Wang
HZHuizhi Zhao
Huizhi Zhao
HZHuan Zhang
Huan Zhang
YXYuanlin Xu
Yuanlin Xu
XAXiuli An
Xiuli An
The erythroblastic island (EBI), composed of a central macrophage and surrounding erythroid cells, was the first hematopoietic niche discovered. The identity of EBI macrophages has thus far remained elusive. Given that Epo is essential for erythropoiesis and that Epor is expressed in numerous nonerythroid cells, we hypothesized that EBI macrophages express Epor so that Epo can act on both erythroid cells and EBI macrophages simultaneously to ensure efficient erythropoiesis. To test this notion, we used Epor-eGFPcre knockin mouse model. We show that in bone marrow (BM) and fetal liver, a subset of macrophages express Epor-eGFP. Imaging flow cytometry analyses revealed that >90% of native EBIs comprised F4/80+Epor-eGFP+ macrophages. Human fetal liver EBIs also comprised EPOR+ macrophages. Gene expression profiles of BM F4/80+Epor-eGFP+ macrophages suggest a specialized function in supporting erythropoiesis. Molecules known to be important for EBI macrophage function such as Vcam1, CD169, Mertk, and Dnase2α were highly expressed in F4/80+Epor-eGFP+ macrophages compared with F4/80+Epor-eGFP− macrophages. Key molecules involved in iron recycling were also highly expressed in BM F4/80+Epor-eGFP+ macrophages, suggesting that EBI macrophages may provide an iron source for erythropoiesis within this niche. Thus, we have characterized EBI macrophages in mouse and man. Our findings provide important resources for future studies of EBI macrophage function during normal as well as disordered erythropoiesis in hematologic diseases such as thalassemia, polycythemia vera, and myelodysplastic syndromes.

18 April 2007 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
DADirk R. Albrecht
Dirk R. Albrecht
GUGregory H. Underhill
Gregory H. Underhill
AMAvital Mendelson
Avital Mendelson
SBSangeeta N. Bhatia
Sangeeta N. Bhatia
Tissues formed by cells encapsulated in hydrogels have uses in biotechnology, cell-based assays, and tissue engineering. We have previously presented a 3D micropatterning technique that rapidly localizes live cells within hydrogels using dielectrophoretic (DEP) forces, and have demonstrated the ability to modulate tissue function through the control of microscale cell architecture. A limitation of this method is the requirement that a single biomaterial must simultaneously harbor biological properties that support cell survival and function and material properties that permit efficient dielectrophoretic patterning. Here, we resolve this issue by forming multiphase tissues consisting of microscale tissue sub-units in a ‘local phase’ biomaterial, which, in turn, are organized by DEP forces in a separate, mechanically supportive ‘bulk phase’ material. We first define the effects of medium conductivity on the speed and quality of DEP cell patterning. As a case study, we then produce multiphase tissues with microscale architecture that combine high local hydrogel conductivity for enhanced survival of sensitive liver progenitor cells with low bulk conductivity required for efficient DEP micropatterning. This approach enables an expanded range of studies examining the influence of 3D cellular architecture on diverse cell types, and in the future may improve the biological function of inhomogeneous tissues assembled from a variety of modular tissue sub-units.